Effectiveness of radiation therapy alone for elderly patients with unresected stage III non-small cell lung cancer

Lung Cancer

Volumn 82, Issue 2, 2013, Pages 266-270

  Sigel, Keith ^a   Lurslurchachai, Linda ^a   Bonomi, Marcelo ^a   Mhango, Grace ^a   Bergamo, Cara ^a   Kale, Minal ^a   Halm, Ethan ^b   Wisnivesky, Juan ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Elderly; Lone radiotherapy; Non small cell lung cancer; Outcomes; Radiotherapy; Toxicity; Unresectable lung cancer

Indexed keywords

AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; ESOPHAGITIS; FEMALE; HOSPITALIZATION; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; RISK ASSESSMENT;

CI; CONFIDENCE INTERVAL; CPT; CURRENT PROCEDURAL TERMINOLOGY; ELDERLY; HAZARD RATIO; HR; LONE RADIOTHERAPY; NON-SMALL CELL LUNG CANCER; NSCLC; ODDS RATIO; OR; OS; OUTCOMES; OVERALL SURVIVAL; PET; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RCT; RT; SEER; SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS; TOXICITY; UNRESECTABLE LUNG CANCER;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; SEER PROGRAM; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84887017079     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.06.011     Document Type: Article

References (26)

1. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 1997, 111:1710-1717.
2. Sause W., Kolesar P., Taylor S.I., Johnson D., Livingston R., Komaki R., et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 2000, 117:358-364.
3. Atagi S., Kawahara M., Yokoyama A., Okamoto H., Yamamoto N., Ohe Y., et al. Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301). Lancet Oncol 2012, 671-678.
4. Booton R., Jones M., Thatcher N. Lung cancer 7: management of lung cancer in elderly patients. Thorax 2003, 58:711-720.
5. Ramnath N., Dilling T.J., Harris L.J., Kim A.W., Michaud G.C., Balekian A.A., et al. Treatment of stage III non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians Evidence-based clinical practice guidelines. Chest 2013, 143:e314S-340S.
6. Brundage M.D., Bezjak A., Dixon P., Grimard L., Larochelle M., Warde P., et al. The role of palliative thoracic radiotherapy in non-small cell lung cancer. Can J Oncol 1996, 6(Suppl 1):25-32.
7. Fairchild A., Harris K., Barnes E., Wong R., Lutz S., Bezjak A., et al. Palliative thoracic radiotherapy for lung cancer: a systematic review. J Clin Oncol 2008, 26:4001-4011.
8. Wisnivesky J.P., Bonomi M., Lurslurchachai L., Mhango G., Halm E.A. Radiotherapy and chemotherapy for elderly patients with stage I-II unresected lung cancer. Eur Respir J 2012, 40:957-964.
9. Perry M., Yarbro J. Toxicity of Chemotherapy 1984, Grune and Straton, Orlando, FL.
10. Repetto L., Balducci L. A case for geriatric oncology. Lancet Oncol 2002, 3:289-297.
11. Havlik R.J., Yancik R., Long S., Ries L., Edwards B. The National Institute on Aging and the National Cancer Institute SEER collaborative study on comorbidity and early diagnosis of cancer in the elderly. Cancer 1994, 74:2101-2106.
12. Hutchins L.F., Unger J.M., Crowley J.J., Coltman C.A., Albain K.S. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999, 341:2061-2067.
13. Detterbeck F.C., Boffa D.J., Tanoue L.T. The new lung cancer staging system. Chest 2009, 136:260-271.
14. Virnig B.A., Warren J.L., Cooper G.S., Klabunde C.N., Schussler N., Freeman J. Studying radiation therapy using SEER-Medicare-linked data. Med Care 2002, 40:IV-49-IV-54.
15. Goldsmith B., Cesaretti J., Wisnivesky J.P. Radiotherapy planning complexity and survival after treatment of advanced stage lung cancer in the elderly. Cancer 2009, 115:4865-4873.
16. Park C.H., Bonomi M., Cesaretti J., Neugut A.I., Wisnivesky J.P. Effect of radiotherapy planning complexity on survival of elderly patients with unresected localized lung cancer. Int J Radiat Oncol Biol Phys 2011, 81:706-711.
17. Du X.L., Osborne C., Goodwin J.S. Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. J Clin Oncol 2002, 20:4636-4642.
18. Wei L., Lin D., Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc 1989, 84:1063-1065.
19. Roswit B., Patno M., Rapp R., Veinbergs A., Feder B., Stuhlbarg J., et al. The survival of patients with inoperable lung cancer: a large-scale randomized study of radiation therapy versus placebo. Radiology 1968, 90:688-697.
20. Kepka L., Olszyna-Serementa M. Palliative thoracic radiotherapy for lung cancer. Expert Rev Anticancer Ther 2010, 10:559-569.
21. Sause W.T., Scott C., Taylor S., Johnson D., Livingston R., Komaki R., et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst 1995, 87:198-205.
22. Perez C.A., Stanley K., Rubin P., Kramer S., Brady L., Perez-Tamayo R., et al. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group. Cancer 1980, 45:2744-2753.
23. Lonardi F., Coeli M., Pavanato G., Adami F., Gioga G., Campostrini F. Radiotherapy for non-small cell lung cancer in patients aged 75 and over: safety, effectiveness and possible impact on survival. Lung Cancer 2000, 28:43-50.
24. Schaake-Koning C., van den Bogaert W., Dalesio O., Festen J., Hoogenhout J., van Houtte P., et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 1992, 326:524-530.
25. O'Rourke N., Roque I.F.M., Farre Bernado N., Macbeth F. Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database Syst Rev 2010, 1:1-47.
26. Timmerman R., Paulus R., Galvin J., Michalski J., Straube W., Bradley J., et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010, 303:1070-1076.